Fairmount Healthcare Fund II L.P. - Insider Non-Derivative Transactions at Zenas BioPharma, Inc. (ZBIO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 16, 2024, Fairmount Healthcare Fund II L.P.'s relationship to Zenas BioPharma, Inc. (ZBIO) is Director, and currently has 1,604,891 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZBIO insiders.
Data Source: SEC.
Fairmount Healthcare Fund II L.P. - Insider Non-Derivative Transactions at ZBIO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 17, 2024 | C -- (Common Stock) | 41130 | 0 | 41140 |
| Sep 17, 2024 | C -- (Common Stock) | 252890 | 0 | 294020 |
| Sep 17, 2024 | C -- (Common Stock) | 709794 | 0 | 1003814 |
| Sep 17, 2024 | C -- (Common Stock) | 301077 | 0 | 1304891 |
| Sep 17, 2024 | P -- (Common Stock) | 300000 | 17 | 1604891 |